H-1B sponsorship profile: Aurobindo Pharma USA, Inc. Across U.S. Department of Labor LCA disclosures, Aurobindo Pharma USA, Inc filed 20 Labor Condition Applications covering 20 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (20 certified of 20 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Aurobindo Pharma USA, Inc’s H-1B petitions range from $63,565 at the low end to $290,000 at the high end, with a petition-weighted average of $111,003. That range reflects the mix of occupations the company sponsors, led by Financial and Investment Analyst (2 petitions at $98,000 avg), followed by Vice President, Finance and Software and AI Analyst. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Aurobindo Pharma USA, Inc is headquartered in East Windsor, NJ under NAICS code 424210, and places H-1B workers across 3 states, most heavily in NJ, NC, FL. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Aurobindo Pharma USA, Inc ranks. By H-1B petition volume, Aurobindo Pharma USA, Inc is #10,148 of 119,880 employers nationally and #946 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.